Literature DB >> 16355039

Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol.

Gerhard H Simon1, Johannes von Vopelius-Feldt, Yanjun Fu, Juergen Schlegel, Guido Pinotek, Michael F Wendland, Mei-Hsiu Chen, Heike E Daldrup-Link.   

Abstract

OBJECTIVES: We sought to compare the ability of 3 ultrasmall superparamagnetic iron oxides (USPIOs) to detect and characterize antigen-induced arthritis with MR imaging.
MATERIALS AND METHODS: A monoarthritis was induced in the right knee of 18 rats. The left knee served as a normal control. Knees underwent magnetic resonance (MR) imaging before, up to 2 hours, and 24 hours after injection (p.i.) of 200 mumol Fe/kg SHU 555 C (n= 6), ferumoxtran-10 (n = 6), or ferumoxytol (n = 6), using T2-2D-SE 100/20,40,60,80/90 (TR/TE/flipangle), T2*-3D-spoiled gradient recalled (SPGR) 100/15/38, and T1-3D-SPGR 50/1,7/60 sequences.
RESULTS: Quantitative signal to noise ratio and DeltaSI data of arthritic knees on T1- and T2*-weighted MR images showed no significant differences between the 3 USPIOs (P > 0.05). At 2 hours p.i., SNR and DeltaSI data were significantly increased from baseline on T1-weighted images and significantly decreased on T2*-weighted images (P < 0.001). At 24 hours p.i., the T1-enhancement returned to baseline, whereas the T2*-enhancement remained significantly elevated (P < 0.001). Immunostains demonstrated an USPIO compartmentalization in macrophages in the arthritic synovium.
CONCLUSIONS: Based on the relatively small number of animals in our study group, inflammation in antigen-induced arthritis can be equally detected and characterized with any of the three USPIOs evaluated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16355039     DOI: 10.1097/01.rli.0000191367.61306.83

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  43 in total

1.  Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle.

Authors:  Miles A Miller; Suresh Gadde; Christina Pfirschke; Camilla Engblom; Melissa M Sprachman; Rainer H Kohler; Katherine S Yang; Ashley M Laughney; Gregory Wojtkiewicz; Nazila Kamaly; Sushma Bhonagiri; Mikael J Pittet; Omid C Farokhzad; Ralph Weissleder
Journal:  Sci Transl Med       Date:  2015-11-18       Impact factor: 17.956

Review 2.  [Macrophage specific MRI imaging for antigen induced arthritides. A potential new strategy for the diagnosis of rheumatoid arthritis].

Authors:  G H Simon; H E Daldrup-Link; E J Rummeny
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

Review 3.  [Molecular and parametric imaging with iron oxides].

Authors:  L Matuszewski; B Tombach; W Heindel; C Bremer
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

4.  USPIO-enhanced magnetic resonance imaging of the knee in asymptomatic volunteers.

Authors:  C S Reiner; A M Lutz; F Tschirch; J M Froehlich; S Gaillard; B Marincek; D Weishaupt
Journal:  Eur Radiol       Date:  2009-03-28       Impact factor: 5.315

Review 5.  The application of super paramagnetic iron oxide-labeled mesenchymal stem cells in cell-based therapy.

Authors:  Yiying Qi; Gang Feng; Zhongming Huang; Weiqi Yan
Journal:  Mol Biol Rep       Date:  2012-12-27       Impact factor: 2.316

Review 6.  In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

Authors:  Hamed Arami; Amit Khandhar; Denny Liggitt; Kannan M Krishnan
Journal:  Chem Soc Rev       Date:  2015-09-21       Impact factor: 54.564

Review 7.  Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.

Authors:  Gerda B Toth; Csanad G Varallyay; Andrea Horvath; Mustafa R Bashir; Peter L Choyke; Heike E Daldrup-Link; Edit Dosa; John Paul Finn; Seymur Gahramanov; Mukesh Harisinghani; Iain Macdougall; Alexander Neuwelt; Shreyas S Vasanawala; Prakash Ambady; Ramon Barajas; Justin S Cetas; Jeremy Ciporen; Thomas J DeLoughery; Nancy D Doolittle; Rongwei Fu; John Grinstead; Alexander R Guimaraes; Bronwyn E Hamilton; Xin Li; Heather L McConnell; Leslie L Muldoon; Gary Nesbit; Joao P Netto; David Petterson; William D Rooney; Daniel Schwartz; Laszlo Szidonya; Edward A Neuwelt
Journal:  Kidney Int       Date:  2017-04-20       Impact factor: 10.612

8.  Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI.

Authors:  Aman Khurana; Hossein Nejadnik; Fanny Chapelin; Olga Lenkov; Rakhee Gawande; Sungmin Lee; Sandeep N Gupta; Nooshin Aflakian; Nikita Derugin; Solomon Messing; Guiting Lin; Tom F Lue; Laura Pisani; Heike E Daldrup-Link
Journal:  Nanomedicine (Lond)       Date:  2013-03-27       Impact factor: 5.307

9.  Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults.

Authors:  Anne M Muehe; Dan Feng; Rie von Eyben; Sandra Luna-Fineman; Michael P Link; Travis Muthig; Amy E Huddleston; Edward A Neuwelt; Heike E Daldrup-Link
Journal:  Invest Radiol       Date:  2016-04       Impact factor: 6.016

10.  Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells.

Authors:  Tobias D Henning; Michael F Wendland; Daniel Golovko; Elizabeth J Sutton; Barbara Sennino; Farbod Malek; Jan S Bauer; Donald M McDonald; Heike Daldrup-Link
Journal:  Magn Reson Med       Date:  2009-08       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.